The value of hysteroscopic-based decision-making in uterine abnormalities during tamoxifen intake in breast cancer patients – preliminary report

Iwona Gabriel; Anita Olejek

doi:10.5114/wiitm.2013.40106

!!!NEW!!! CLINICAL FORUM !!!NEW!!!
to make the quarterly livelier and more beneficial for doctors and scientists !!!

On June the 1st, 2021 VSJ launches a new discussion platform in the journal.

We invite all MIS surgeons to rapidly submit for publication:
- small forms describing unusual clinical situations related to their practice,
- short clinical comments relating to any publications in VSJ, including the clinical situations described above
- brief communications of original studies deserving fast publication
- your personal opinions as part of a larger discussion on the VSJ publication
- letters concerning the topics described above

Clinical Forum gives you a means of rapid presentation of your findings in the medical databases, scientific citations on the international forum, and also an Impact Factor!

For further details, see: Instructions for Authors

eISSN: 2299-0054
ISSN: 1895-4588

Videosurgery and Other Miniinvasive Techniques

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2014
vol. 9

Send email

Copy url:

abstract:

Short communication

The value of hysteroscopic-based decision-making in uterine abnormalities during tamoxifen intake in breast cancer patients – preliminary report

Iwona Gabriel

,

Anita Olejek

Videosurgery Miniinv 2014; 9 (2): 258–261

DOI: https://doi.org/10.5114/wiitm.2013.40106

Online publish date: 2014/01/23

View full text Get citation

PlumX metrics:

Women using hormonal therapy for breast cancer are often encountered in clinical practice of breast surgeons, oncologists and gynecologists. Some of them during the course of therapy develop abnormal uterine bleeding or have ultrasound abnormalities detected. In Poland, most of them are still diagnosed using blind curettage, which does not bring a definitive diagnosis or requires repeating the diagnostic procedure. This produces unnecessary fear of malignancy in patients and increases economic costs (double curettage, unnecessary hysterectomy and its social consequences). Therefore, we studied the usefulness of hysteroscopy with targeted biopsies for further management of women treated with tamoxifen. Our goal is to provide evidence that women before entering, during and after tamoxifen treatment have hysteroscopy for endometrial assessment.

keywords:

The value of hysteroscopic-based decision-making in uterine abnormalities during tamoxifen intake in breast cancer patients – preliminary report

Iwona Gabriel , Anita Olejek

tamoxifen, hysteroscopy, breast cancer, endometrium, assessment

Iwona Gabriel

,

Anita Olejek